Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant in Androgen Independent Prostate Cancer
NCT00244998Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in prostate cancer (PCa), sponsored by Roswell Park Comprehensive Cancer Center. Started Sep 2005; status: completed.
02
Drugs
fulvestrant
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00244998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244998.